- Pivotal bioVenture Partners (US)
Global Life Sciences Venture Capital Investor (excluding Asia)
SPOTLIGHT ON PIVOTAL U.S.
"Treasure your curiosity and nurture your imagination.”
Shirley Ann Jackson Ph.D.
APPROACH + STRATEGY
Our life sciences venture capital investment team in the U.S.
We are a venture capital fund investing in privately held North American and European companies seeking companies with innovative therapeutic products and platforms that address major, unmet medical needs.
Life
Sciences
WHAT WE DO
We back the brightest minds in life sciences.
Our seasoned investment team brings over 50 years combined biotech venture capital and company building experience from top tier funds including Novo Ventures, TPG Biotech, Bay City Capital, NEA, and SV Life Sciences. We strive to leverage this extended network and expertise in evaluating new investment opportunities, building value in our portfolio, and in contributing management talent and referrals to our companies.
We invest at all stages in a company’s evolution, from company creation through mid and late stage clinical development. We are capable of leading or co-leading transactions, and employ a rigorous investment review process that distinguishes us and helps us with syndicate building and positioning companies well for a future public offering or M&A event.
CONTACT
Pivotal bioVenture Partners (US)
501 2nd Street, Suite 200
San Francisco, CA 94107
San Francisco, CA 94107